Stock comparison
Mettler-Toledo International
Bio-Techne
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
MTD
Mettler-Toledo International
Market cap
$22.29B
Sector
Healthcare
TECH
Bio-Techne
Market cap
$7.55B
Sector
Healthcare
Overall winner
Mettler-Toledo International MTD
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | MTD | TECH | Winner |
|---|---|---|---|
| Warren Buffett | 69B | 55C | MTD |
| Benjamin Graham | 65B | 89A | TECH |
| Philip Fisher | 63C | 50C | MTD |
| Peter Lynch | 66B | 24F | MTD |
| Joel Greenblatt | 68B | 50D | MTD |
| Charlie Munger | 74B | 45D | MTD |
| Terry Smith | 70B | 44D | MTD |
Side-by-side metrics
| Metric | MTD | TECH |
|---|---|---|
| Market cap | $22.29B | $7.55B |
| P/E (TTM) | 25.3x | 61.6x |
| EV/EBIT | 21.6x | 67.1x |
| ROIC (TTM) | 36.09% | 4.75% |
| Gross margin | 57.79% | 64.96% |
| Net margin | 21.4% | 9.05% |
| Revenue CAGR 5y | 2.01% | 6.98% |
| EPS CAGR 5y | 6.12% | -15.23% |
| Debt / Equity | - | 0.1x |
| Dividend yield | 0.0% | 0.74% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
MTD leads on
- EPS CAGR 5y6.12%vs -15.23%+140%
- Debt / Equity-vs 0.1x+100%
- ROIC (TTM)36.09%vs 4.75%+87%
- EV/EBIT21.6xvs 67.1x+68%
TECH leads on
- Dividend yield0.74%vs 0.0%+100%
- Revenue CAGR 5y6.98%vs 2.01%+71%
- Gross margin64.96%vs 57.79%+11%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.